-
Real-World Clinical Outcomes, Healthcare Resource Utilization, and Direct Medical Costs in Atrial Fibrillation Patients Receiving Catheter Ablation in Japan
Mar 10, 2025, 14:00 PM -
US Physician Characteristics Associated With Real-World Evidence Implementation in Oncology Practice
Mar 10, 2025, 14:00 PM -
Key Considerations in the Use of Large Language Models for Data Extraction in Health Economics and Outcomes Research
Mar 10, 2025, 14:00 PM -
US Food and Drug Administration Authorizations of Therapeutic Biologics and Biosimilars, 1980-2024
Mar 10, 2025, 14:00 PM -
Healthcare Cost and Resource Utilization among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US
Mar 10, 2025, 14:00 PM -
Economic Evaluation of NT-proBNP Testing to Facilitate Prevention of Heart Failure in Adults With Type 2 Diabetes
Mar 10, 2025, 14:00 PM -
Fostering the Identification and Dissemination ofHealth Technology Assessment Studies: The Brazilian HTA Database Case Study
Mar 10, 2025, 14:00 PM -
Validity and Accuracy of Asthma-Related ICD-10 Diagnosis Codes in United States Real-World Administrative Database
Mar 10, 2025, 14:00 PM -
Impact of Post-Discharge Rifaximin Use Following an Overt Hepatic Encephalopathy (OHE) Hospitalization on Annual Rates of OHE Rehospitalization in the United States
Mar 10, 2025, 14:00 PM -
Association of Chronic Conditions and Medication Burden with Patient Preferences for Long-Acting Antiretroviral Therapy in HIV Treatment
Mar 10, 2025, 14:00 PM -
A Targeted Literature Review of Value-Based Agreements (VBAs) for Cell and Gene Therapies in the United States
Mar 10, 2025, 14:00 PM -
Geographic Variation in Lower Limb Prosthesis Prescription Disparities Between White and Black Veterans: A Retrospective Cohort Analysis (2010 - 2022)
Mar 10, 2025, 14:00 PM -
Machine Learning for Predictive Modeling of Hospitalization Risk in Myasthenia Gravis Patients Using the MGFA Global Patient Registry: Addressing Imbalanced Data in Real-World Evidence Scenarios
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns Among Patients With Scalp Psoriasis in Canada
Mar 10, 2025, 14:00 PM -
Household Costs and Other Societal Impacts for Individuals With Duchenne Muscular Dystrophy Stratified by Upper Limb Impairment: Results From a Caregiver Survey
Mar 10, 2025, 14:00 PM -
Treatment Patterns and Efficacy/Safety of the Drugs in HER2+ NSCLC: A Systemic Literature Review
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Intravenous Ferric Carboxy Maltose Versus Iron Sucrose to Treat Anemia in Pregnancy in Indian Context
Mar 10, 2025, 14:00 PM -
Functional, Fatiguability and Quality of Life (QoL) Endpoints for Spinal Muscular Atrophy (SMA) Clinical Trials: Perception by Health Technology Assessment (HTA) Bodies and Regulators and Validation Status
Mar 10, 2025, 14:00 PM -
ICER Thresholds in Cost-Utility Analysis: Assessing Conceptual Relevance and Practical Adequacy for Drug Reimbursement Decision-Making in The US
Mar 10, 2025, 14:00 PM -
Productivity Loss And Indirect Costs Of Heart Failure: Analysis Of The Brazilian Social Security System
Mar 10, 2025, 14:00 PM